Mondias announces the results of its annual meeting

MONTREAL, Sept. 14, 2020 /CNW/ - Mondias Natural Products Inc.  (TSXV: NHP) (the "Company" or "Mondias ") is pleased to announce the results of its annual general and special meeting of shareholders (the "Meeting"), which was held earlier today by webcast. All of the nominees listed in the Company's management information circular dated August 14, 2020, were elected as directors.

Detailed results of the vote for the election of directors are set out below:

Nominee	Votes FOR	% FOR	Votes Withheld	% Withheld
Marie Bélanger	39,207,298	91.11%	3,823,406	8.89
Kevin Cole	39,207,298	91.11%	3,823,406	8.89
Nathalie Nasseri	39,207,298	91.11%	3,823,406	8.89
Mario Paradis	39,207,298	91.11%	3,823,406	8.89
Kevin Roland	39,207,298	91.11%	3,823,406	8.89

All other matters presented for shareholder approval at the Meeting were approved, as follows:

• to set the number of directors at a minimum of three (3) and maximum of seven (7);
• to appoint UHY McGovern Hurley LLP, Chartered Accountants as the auditors of the Corporation and to authorize the directors to fix the auditors' remuneration;
• to consider, and if deemed advisable, to pass, with or without variation, an ordinary resolution confirming re-approval of the Corporation's incentive stock option plan;
• to consider, and if deemed advisable, to pass, with or without variation, an ordinary resolution authorizing and approving the acquisition of 100% of the issued and outstanding common shares of Lumiera Health Innovation Inc.; and
• to consider and, if deemed appropriate, to pass, with or without variation, a special resolution approving, ratifying and confirming a change of name of the Corporation from"Mondias Natural Products Inc."/"Produits Naturels Mondias inc." to "Lumiera Health Innovation Inc.";

About Mondias Natural Products Inc.

Mondias specializes in the commercialization and development of evidence-based botanical products for the healthcare and bio-agriculture. The Company sells both oral and topical botanical agents to help manage unmet medical needs through its Holizen Laboratories division. Mondias is also developing botanical-based specialty fertilizers for use on household plants, lawns and golf courses and in urban gardens, nurseries and greenhouses, in collaboration with McGill's Faculty of Agricultural and Environmental Sciences. For more information, visit: www.mondias.ca  

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than statements of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by the use of the words "may", "will", "should", "continue", "expect", "anticipate", "estimate", "believe", "intend", "plan" or "project" or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company's ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include the Company's inability to obtain sufficient financing to execute its business plan; competition; regulation; anticipated and unanticipated costs and delays; the success of the Company's research and development strategies; the ability to obtain orphan drug status; the applicability of the discoveries made; the successful and timely completion and uncertainties related to the regulatory approval process; the timing of clinical trials; the timing and outcomes of regulatory or intellectual property decisions; and other risks disclosed in the Company's public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this news release, and the Company does not undertake any obligation to publicly update them to reflect new information or subsequent events or otherwise except as required by applicable securities legislation.

SOURCE Mondias Natural Products Inc.

Mondias Natural Products Inc., Mario Paradis, Chief Financial Officer, 514-641-0181, [email protected]

Related Links

https://mondias.ca/